The true incidence of AIN is unknown. Definitive diagnosis requires a biopsy, which may not be performed due to subtle clinical presentation or risk factors for complications, and hence the incidence is underestimated. One study found that AIN incidence was 3.2 per 10,000 person-years in users of proton-pump inhibitors.
BMJ Best Practice is an evidence-based point of care tool for healthcare practitioners.
To continue reading and access all of BMJ Best Practice's pages you'll need to log in or start a free trial.
You can access through your institution if your hospital, university, trust or other institution provides access to BMJ Best Practice through either OpenAthens or Shibboleth.
Use of this content is subject to our disclaimer